APA (7th ed.) Citation

Y, G., J, M., Z, F., Y, X., B, G., J, Y., . . . J, C. (2019). Development Of Novel Liposome-Encapsulated Combretastatin A4 Acylated Derivatives: Prodrug Approach For Improving Antitumor Efficacy. Dove Medical Press.

Chicago Style (17th ed.) Citation

Y, Gu, Ma J, Fu Z, Xu Y, Gao B, Yao J, Xu W, Chu K, and Chen J. Development Of Novel Liposome-Encapsulated Combretastatin A4 Acylated Derivatives: Prodrug Approach For Improving Antitumor Efficacy. Dove Medical Press, 2019.

MLA (8th ed.) Citation

Y, Gu, et al. Development Of Novel Liposome-Encapsulated Combretastatin A4 Acylated Derivatives: Prodrug Approach For Improving Antitumor Efficacy. Dove Medical Press, 2019.